pith. sign in

arxiv: 2604.08225 · v1 · submitted 2026-04-09 · ⚛️ physics.optics · cond-mat.mtrl-sci· cond-mat.soft· physics.bio-ph

Comparative performance of three optical biosensing platforms for SARS-CoV-2 antibodies detection in human serum

Agostino Occhicone , Alberto Sinibaldi , Peter Munzert , Jordan N. Butt , Ethan P. Luta , Diego M. Ar\'evalo , Francesco Michelotti , Benjamin L. Miller This is my paper

Pith reviewed 2026-05-10 16:41 UTC · model grok-4.3

classification ⚛️ physics.optics cond-mat.mtrl-scicond-mat.softphysics.bio-ph
keywords optical biosensorsBloch surface wavesmicroring resonatorsSARS-CoV-2 antibodieslabel-free detectionhuman serumserological surveillance
0
0 comments X

The pith

BSW and MRR optical platforms detect SARS-CoV-2 antibodies rapidly and quantitatively in serum without labels.

A machine-rendered reading of the paper's core claim, the machinery that carries it, and where it could break.

The paper compares two label-free optical biosensing platforms, Bloch surface wave and microring resonator, for detecting antibodies to SARS-CoV-2 in human serum. It introduces a new BSW readout system to conduct tests under conditions nearly the same as the existing MRR setup. Both platforms, after attaching viral proteins, capture and measure anti-Spike and anti-Nucleocapsid antibodies quickly and accurately without extra labels. Results match standard long-term serology tests closely and remain consistent across different production batches of the sensor chips.

Core claim

This study establishes that both Bloch surface wave and microring resonator platforms provide rapid, quantitative, and sensitive detection of anti-Spike and anti-Nucleocapsid antibodies in human serum without the need for secondary labels, with excellent agreement with longitudinal serology benchmarks and high repeatability across different biochip batches.

What carries the argument

Functionalization of BSW and MRR sensors with SARS-CoV-2 Spike and Nucleocapsid protein variants for label-free antibody capture and optical readout.

If this is right

  • These technologies become viable low-cost options for clinical diagnostics of SARS-CoV-2 immunity.
  • Serological surveillance can use these platforms for monitoring antibody levels over time.
  • High repeatability across batches supports reliable manufacturing and deployment.
  • Absence of secondary labels simplifies the assay process and lowers reagent costs.

Where Pith is reading between the lines

These are editorial extensions of the paper, not claims the author makes directly.

  • Similar direct comparison methods could standardize performance checks between emerging biosensor types.
  • The label-free approach might extend to detecting antibodies for other viruses in the same setup.
  • Integration with microfluidic systems could further reduce sample volumes needed for testing.

Load-bearing premise

The new BSW readout system was set up to enable assays under nearly identical experimental conditions as the MRR platform.

What would settle it

A larger set of serum samples where BSW and MRR readings deviate significantly from each other or from established serology results would falsify the performance equivalence and agreement claims.

read the original abstract

This study presents a rigorous comparative analysis of two label-free optical biosensing platforms, Bloch surface wave (BSW) and microring resonator (MRR), for the detection of SARS-CoV-2 antibodies in human serum. To ensure direct comparability, a new BSW readout system was established alongside an existing MRR platform, allowing assays to be conducted under nearly identical experimental conditions. Both sensors were functionalized with various SARS-CoV-2 Spike and Nucleocapsid protein variants to capture specific host antibodies. The results demonstrate that both platforms provide rapid, quantitative, and sensitive detection of anti-Spike and anti-Nucleocapsid antibodies without the need for secondary labels. Furthermore, the platforms show excellent agreement with longitudinal serology benchmarks and high repeatability across different biochip batches. This work establishes both BSW and MRR technologies as powerful, low-cost candidates for next-generation clinical diagnostics and serological surveillance.

Editorial analysis

A structured set of objections, weighed in public.

Desk editor's note, referee report, simulated authors' rebuttal, and a circularity audit. Tearing a paper down is the easy half of reading it; the pith above is the substance, this is the friction.

Referee Report

2 major / 2 minor

Summary. The manuscript reports a comparative experimental study of two label-free optical biosensing platforms—Bloch surface wave (BSW) and microring resonator (MRR)—for detecting SARS-CoV-2 anti-Spike and anti-Nucleocapsid antibodies in human serum. A new BSW readout system is developed to enable assays under nearly identical conditions to an existing MRR platform. Both sensors are functionalized with protein variants, and performance is evaluated for sensitivity, quantitative response, agreement with longitudinal serology benchmarks, and repeatability across biochip batches.

Significance. If the central claim of equivalent experimental conditions holds, the work provides a direct, practically relevant head-to-head comparison of two label-free optical technologies using real human serum samples and independent serology benchmarks. Such controlled comparisons are useful for assessing candidates for clinical diagnostics and serological surveillance, particularly given the emphasis on rapid, label-free operation and batch repeatability.

major comments (2)
  1. [Methods] Methods section: The load-bearing claim that the new BSW system enables assays 'under nearly identical experimental conditions' to the MRR platform requires explicit quantitative evidence. No side-by-side parameter table or validation data is provided for biofunctionalization (protein variants and immobilization chemistry), sample handling (serum dilution, matrix effects), fluidics (flow rates, incubation times), or optical settings (wavelength, power, angle, detection scheme). Without these, similarities in sensitivity and repeatability cannot be confidently attributed to intrinsic platform properties rather than setup matching.
  2. [Results] Results section: The assertions of 'excellent agreement with longitudinal serology benchmarks' and 'high repeatability across different biochip batches' are central but lack supporting quantitative details such as correlation coefficients, Bland-Altman analysis, sample sizes, exclusion criteria, or statistical tests for batch variability. Figures and tables should include error bars, replicate numbers, and direct comparison metrics to substantiate the performance equivalence.
minor comments (2)
  1. [Abstract] Abstract: The phrase 'rigorous comparative analysis' is not supported by the level of methodological detail visible; consider softening or moving quantitative claims to the main text.
  2. [Figures] Figure captions: Ensure all panels include scale bars, units, and clear labeling of BSW vs. MRR traces to aid direct visual comparison.

Simulated Author's Rebuttal

2 responses · 0 unresolved

We thank the referee for the constructive and detailed comments. We agree that additional quantitative details will strengthen the manuscript and have prepared revisions to address both major points. Our point-by-point responses follow.

read point-by-point responses

  1. Referee: [Methods] Methods section: The load-bearing claim that the new BSW system enables assays 'under nearly identical experimental conditions' to the MRR platform requires explicit quantitative evidence. No side-by-side parameter table or validation data is provided for biofunctionalization (protein variants and immobilization chemistry), sample handling (serum dilution, matrix effects), fluidics (flow rates, incubation times), or optical settings (wavelength, power, angle, detection scheme). Without these, similarities in sensitivity and repeatability cannot be confidently attributed to intrinsic platform properties rather than setup matching.

    Authors: We acknowledge that the manuscript describes the development of the new BSW readout system to match the MRR platform but does not include an explicit side-by-side parameter table. To resolve this, we will add a new table in the Methods section that directly compares all relevant parameters, including protein variants and immobilization chemistry, serum dilution factors and matrix handling, fluidic conditions (flow rates and incubation times), and optical settings (wavelength, power, angle, and detection scheme). This addition will allow readers to evaluate the degree of experimental equivalence and attribute performance differences to the sensor platforms themselves. revision: yes

  2. Referee: [Results] Results section: The assertions of 'excellent agreement with longitudinal serology benchmarks' and 'high repeatability across different biochip batches' are central but lack supporting quantitative details such as correlation coefficients, Bland-Altman analysis, sample sizes, exclusion criteria, or statistical tests for batch variability. Figures and tables should include error bars, replicate numbers, and direct comparison metrics to substantiate the performance equivalence.

    Authors: We agree that the central claims would benefit from explicit quantitative support. In the revised manuscript we will add Pearson and/or Spearman correlation coefficients for agreement with the longitudinal serology benchmarks, include Bland-Altman plots or analyses where appropriate, state the exact sample sizes and any exclusion criteria applied, and report statistical tests (e.g., ANOVA or t-tests) for batch-to-batch variability. We will also ensure every figure includes error bars (standard deviation or standard error of the mean) with replicate numbers stated in the captions and will add a summary table of direct comparison metrics between the two platforms. revision: yes

Circularity Check

0 steps flagged

No circularity: purely experimental comparison with no derivations or fitted predictions

full rationale

The paper is a comparative experimental study of BSW and MRR optical biosensing platforms for SARS-CoV-2 antibody detection in human serum. All claims rest on direct sensor readouts, biofunctionalization protocols, repeatability across batches, and agreement with independent longitudinal serology benchmarks. There are no mathematical derivations, first-principles predictions, fitted parameters presented as predictions, self-citations of uniqueness theorems, or any chain that reduces a result to its own inputs by construction. The methodological claim of 'nearly identical experimental conditions' is an empirical setup description, not a derivation. This is self-contained against external benchmarks with no circular steps.

Axiom & Free-Parameter Ledger

0 free parameters · 1 axioms · 0 invented entities

The central claim rests on the domain assumption that the BSW and MRR platforms can be operated under nearly identical conditions for fair comparison and that the chosen protein variants enable specific antibody capture. No free parameters or new physical entities are introduced.

axioms (1)
  • domain assumption The new BSW readout system permits assays under nearly identical experimental conditions to the MRR platform.
    Explicitly stated in the abstract as the basis for direct comparability of the two platforms.

pith-pipeline@v0.9.0 · 5502 in / 1419 out tokens · 66996 ms · 2026-05-10T16:41:48.394603+00:00 · methodology

discussion (0)

Sign in with ORCID, Apple, or X to comment. Anyone can read and Pith papers without signing in.

Reference graph

Works this paper leans on

2 extracted references · 2 canonical work pages

  1. [1]

    Disposable Photonics

    (1) Abelès, F. Recherches Sur La Propagation Des Ondes Électromagnétiques Sinusoïdales Dans Les Milieux Stratifiés. Ann. Phys. (Paris). 1950, 12 (5), 596 –640. https://doi.org/10.1051/anphys/195012050596. (2) Sinibaldi, A.; Danz, N.; Descrovi, E.; Munzert, P.; Schulz, U.; Sonntag, F.; Dominici, L.; Michelotti, F. Direct Comparison of the Performance of Bl...

    work page doi:10.1051/anphys/195012050596 1950

  2. [2]

    https://doi.org/10.1016/j.ab.2023.115263

    work page doi:10.1016/j.ab.2023.115263 2023